Home LiteratureArticle Details
PMID: 12682064 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney.

The Journal of biological chemistry ·Vol. 278 ·No. 29 ·2003-07-18 ·Pages 27256-66

Park KM, Byun JY, Kramers C, Kim JI, Huang PL, Bonventre JV

Abstract

Ischemic preconditioning renders the mouse kidney resistant to subsequent ischemia. Understanding the mechanisms responsible for ischemic preconditioning is important for formulating therapeutic strategies aimed at mimicking protective mechanisms. We report that the resistance afforded by 30 min of bilateral kidney ischemia persists for 12 weeks after preconditioning. The protection is reflected by improved postischemic renal function, reduced leukocyte infiltration, reduced postischemic disruption of the actin cytoskeleton, and reduced postischemic expression of kidney injury molecule-1 (Kim-1). The protection is observed in both BALB/c and C57BL/6J strains of mice. Thirty minutes of prior ischemia increases the expression of inducible nitric-oxide synthase (iNOS) and endothelial NOS (eNOS) and the expression of heat shock protein (HSP)-25 and is associated with increased interstitial expression of alpha-smooth muscle actin (alpha-SMA), an indication of long term postischemic sequelae. Treatment with Nomega-nitro-l-arginine (l-NNA), an inhibitor of NO synthesis, increases kidney susceptibility to ischemia. Gene deletion of iNOS increases kidney susceptibility to ischemia, whereas gene deletion of eNOS has no effect. Pharmacological inhibition of NOS by l-NNA or l-N6-(1-iminoethyl) lysine (l-NIL, a specific inhibitor of iNOS) mitigates the kidney protection afforded by 30 min of ischemic preconditioning. Fifteen minutes of prior ischemic preconditioning, which does not result in the disruption of the actin cytoskeleton, impairment of renal function, increased interstitial alpha-SMA, or increased iNOS or eNOS expression, but does increase HSP-25 expression, partially protects the kidney from ischemia on day 8 via a mechanism that is not abolished by l-NIL treatment. Thus, iNOS is responsible for a significant component of the long term protection afforded the kidney by ischemic preconditioning, which results in persistent renal interstitial disease, but does not explain the preconditioning seen with shorter periods of ischemia.

MeSH Terms
Actins/metabolism Animals Arginine/pharmacology Cytoskeleton/metabolism Enzyme Inhibitors/pharmacology Heat-Shock Proteins Ischemic Preconditioning Kidney/blood supply,drug effects,enzymology,injuries Male Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Knockout Molecular Chaperones Neoplasm Proteins/metabolism Nitric Oxide Synthase/antagonists & inhibitors,deficiency,genetics,metabolism Nitric Oxide Synthase Type II Nitric Oxide Synthase Type III Nitroarginine/pharmacology Reperfusion Injury/drug therapy,enzymology,prevention & control
Chemicals
Actins Enzyme Inhibitors Heat-Shock Proteins Hsbp1 protein, mouse Molecular Chaperones Neoplasm Proteins Nitroarginine Arginine Nitric Oxide Synthase Nitric Oxide Synthase Type II Nitric Oxide Synthase Type III Nos2 protein, mouse Nos3 protein, mouse
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Park Kwon Moo
Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Byun Ji-Yeon
Kramers Cornelis
Kim Jee In
Huang Paul L
Bonventre Joseph V
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2003-07-18
Epub
2003-00-07
Pages
27256-66
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NIDDK NIH HHS · DK 38452 · United States
NIDDK NIH HHS · DK 39773 · United States
NINDS NIH HHS · NS 10828 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com